Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Zhan MX"" wg kryterium: Autor


Wyświetlanie 1-4 z 4
Tytuł:
Ulinastatin Exhibits Antinociception in Rat Models of Acute Somatic and Visceral Pain Through Inhibiting the Local and Central Inflammation
Autorzy:
Zhan MX
Tang L
Lu YF
Wu HH
Guo ZB
Shi ZM
Yang CL
Zou YQ
Yang F
Chen GZ
Pokaż więcej
Temat:
ulinastatin
formalin
somatic pain
visceral pain
inflammation
antinociception
Medicine (General)
R5-920
Źródło:
Journal of Pain Research, Vol Volume 14, Pp 1201-1214 (2021)
Opis pliku:
electronic resource
Relacje:
https://www.dovepress.com/ulinastatin-exhibits-antinociception-in-rat-models-of-acute-somatic-an-peer-reviewed-fulltext-article-JPR; https://doaj.org/toc/1178-7090
Dostęp URL:
https://doaj.org/article/3dcda7f8d41d4560a476a86362692e4d  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
Activation of MET promotes resistance to sorafenib in hepatocellular carcinoma cells via the AKT/ERK1/2-EGR1 pathway.
Autorzy:
Xiang QF; a Department of Hepatobiliary Surgery , Sun Yat-Sen University Cancer Center , Guangzhou , China.; b Department of General Surgery , Zhuhai People's Hospital, Zhuhai Hospital of Jinan University , Zhuhai , China.
Zhan MX; c Zhuhai Interventional Medical Center, Zhuhai Precision Medicine Center , Zhuhai People's Hospital , Zhuhai Hospital of Jinan University , Zhuhai , China.
Li Y; c Zhuhai Interventional Medical Center, Zhuhai Precision Medicine Center , Zhuhai People's Hospital , Zhuhai Hospital of Jinan University , Zhuhai , China.
Liang H; b Department of General Surgery , Zhuhai People's Hospital, Zhuhai Hospital of Jinan University , Zhuhai , China.
Hu C; b Department of General Surgery , Zhuhai People's Hospital, Zhuhai Hospital of Jinan University , Zhuhai , China.
Huang YM; b Department of General Surgery , Zhuhai People's Hospital, Zhuhai Hospital of Jinan University , Zhuhai , China.
Xiao J; c Zhuhai Interventional Medical Center, Zhuhai Precision Medicine Center , Zhuhai People's Hospital , Zhuhai Hospital of Jinan University , Zhuhai , China.
He X; c Zhuhai Interventional Medical Center, Zhuhai Precision Medicine Center , Zhuhai People's Hospital , Zhuhai Hospital of Jinan University , Zhuhai , China.
Xin YJ; c Zhuhai Interventional Medical Center, Zhuhai Precision Medicine Center , Zhuhai People's Hospital , Zhuhai Hospital of Jinan University , Zhuhai , China.
Chen MS; a Department of Hepatobiliary Surgery , Sun Yat-Sen University Cancer Center , Guangzhou , China.
Lu LG; c Zhuhai Interventional Medical Center, Zhuhai Precision Medicine Center , Zhuhai People's Hospital , Zhuhai Hospital of Jinan University , Zhuhai , China.
Pokaż więcej
Źródło:
Artificial cells, nanomedicine, and biotechnology [Artif Cells Nanomed Biotechnol] 2019 Dec; Vol. 47 (1), pp. 83-89.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular/*pathology
Drug Resistance, Neoplasm/*drug effects
Liver Neoplasms/*pathology
MAP Kinase Signaling System/*drug effects
Proto-Oncogene Proteins c-met/*metabolism
Sorafenib/*pharmacology
Apoptosis/drug effects ; Cell Proliferation/drug effects ; Down-Regulation/genetics ; Drug Interactions ; Early Growth Response Protein 1/deficiency ; Early Growth Response Protein 1/genetics ; Early Growth Response Protein 1/metabolism ; Enzyme Activation/drug effects ; Enzyme Inhibitors/pharmacology ; Hep G2 Cells ; Hepatocyte Growth Factor/pharmacology ; Humans ; Mitogen-Activated Protein Kinase 1/metabolism ; Mitogen-Activated Protein Kinase 3/metabolism ; Proto-Oncogene Proteins c-akt/metabolism ; RNA, Small Interfering/genetics
Czasopismo naukowe
Tytuł:
Combination of the neutrophil to lymphocyte ratio and the platelet to lymphocyte ratio as a useful predictor for recurrence following radiofrequency ablation of hepatocellular carcinoma.
Autorzy:
Chen K; The Second Clinical Medical College, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China.; Department of Interventional Radiology, Cancer Center, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong 510080, P.R. China.
Zhan MX; Department of Interventional Radiology, Cancer Center, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong 510080, P.R. China.
Hu BS; Department of Interventional Radiology, Cancer Center, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong 510080, P.R. China.
Li Y; Department of Interventional Radiology, Cancer Center, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong 510080, P.R. China.
He X; Department of Interventional Radiology, Cancer Center, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong 510080, P.R. China.
Fu SR; Department of Interventional Radiology, Cancer Center, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong 510080, P.R. China.
Xin YJ; Department of Interventional Radiology, Cancer Center, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong 510080, P.R. China.
Lu LG; The Second Clinical Medical College, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China.; Department of Interventional Radiology, Cancer Center, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong 510080, P.R. China.
Pokaż więcej
Źródło:
Oncology letters [Oncol Lett] 2018 Jan; Vol. 15 (1), pp. 315-323. Date of Electronic Publication: 2017 Oct 30.
Typ publikacji:
Journal Article
Czasopismo naukowe
    Wyświetlanie 1-4 z 4

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies